Role of Collagen Conduit With Duloxetine and/or Pregabalin in the Management of Partial Peripheral Nerve Injury

J Oral Maxillofac Surg. 2016 Jun;74(6):1120-30. doi: 10.1016/j.joms.2016.01.022. Epub 2016 Jan 21.

Abstract

Purpose: The objective of this study was to investigate the analgesic effect of a collagen conduit (Neuragen, Integra LifeSciences Corp, Plainsboro, NJ) using duloxetine (Cymbalta, Lilly, Indianapolis, IN) with or without pregabalin (Lyrica, Pfizer, NY) on pain induced by partial sciatic nerve transection in a rat model.

Material and methods: Adult male Sprague-Dawley rats were divided into 5 groups (n = 10 per group): group 1, nerve damage with no treatment; group 2, nerve damage treated with the application of a collagen conduit and saline; group 3, nerve damage treated with the application of a collagen conduit and duloxetine; group 4, nerve damage treated with the application of a collagen conduit and pregabalin; and group 5, nerve damage treated with the application of a collagen conduit and pregabalin plus duloxetine. Pain levels were evaluated by responses to mechanical and thermal stimuli at baseline before and 3 and 7 days after surgery. Interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF) levels were evaluated in blood, sciatic nerve, and dorsal root ganglion samples collected 7 days after surgery.

Results: The group treated with the collagen conduit and pregabalin exhibited markedly less pain 7 days postoperatively in response to mechanical and thermal stimuli compared with the other groups. IL-10 levels were considerably increased in the group treated with pregabalin. The groups treated with a collagen conduit and duloxetine and a combination of pregabalin and duloxetine also exhibited markedly less pain in response to mechanical and thermal stimuli 7 days after surgery compared with the group that had only nerve injury. The decrease in pain using duloxetine was not as robust but was associated with a decrease of TNF-α. The combination of pregabalin and duloxetine resulted in a substantial decrease in IL-6.

Conclusion: Using a collagen conduit and duloxetine, pregabalin, and their combination helped alleviate neuropathic pain. The mechanism of action might be associated, at least in part, to cytokines.

MeSH terms

  • Analgesics / administration & dosage
  • Analgesics / therapeutic use*
  • Animals
  • Collagen / therapeutic use*
  • Drug Therapy, Combination
  • Duloxetine Hydrochloride / administration & dosage
  • Duloxetine Hydrochloride / therapeutic use*
  • Male
  • Neuralgia / drug therapy*
  • Neuralgia / etiology
  • Pain Measurement
  • Peripheral Nerve Injuries / complications
  • Peripheral Nerve Injuries / drug therapy*
  • Pharmaceutical Vehicles
  • Pregabalin / administration & dosage
  • Pregabalin / therapeutic use*
  • Rats
  • Rats, Sprague-Dawley
  • Sciatic Nerve / injuries

Substances

  • Analgesics
  • Pharmaceutical Vehicles
  • Pregabalin
  • Collagen
  • Duloxetine Hydrochloride